pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
THERAPEUTIC AREA
save

Cardiology

Diseases of the heart and cardiovascular system.

also known as: cardiovascular, cardio, cv, heart

🐶 often sniffed alongside

top 8
  • tagAdCom616 co-mentions · 607 sources
  • tag510(k) Clearance572 co-mentions · 566 sources
  • tagRecall165 co-mentions · 45 sources
  • tagHematology110 co-mentions · 65 sources
  • tagHeart Failure57 co-mentions · 18 sources
  • tagUrology53 co-mentions · 3 sources
  • tagEndocrinology & Metabolism52 co-mentions · 7 sources
  • tagPMA Approval44 co-mentions · 41 sources
drugs
425
catalysts
37
news
2,860
companies
317

Top drugs

view all →
Marketed
ALDACTAZIDE
Hepatic Edema
$PFE · 145 catalysts
Marketed
adrenaline
Hypotension
113 catalysts
Marketed
VALPROIC ACID
Pulmonary Arterial Hypertension
81 catalysts
Marketed
tocilizumab
Coronavirus Disease 2019 (COVID-19)
61 catalysts
Marketed
HEPARIN SODIUM
$PFE · 53 catalysts
Marketed
Laryng-O-Jet
Local Anesthetic Effect
50 catalysts
Marketed
GLYCOPYRROLATE
Anesthetic Effect
48 catalysts
Marketed
methylprednisolone sodium succinate
Drug Hypersensitivity Reactions
48 catalysts

🐶 Top companies

view all →
  • $PFEPFIZER INC
    9 products
  • Teva Pharmaceuticals USA Inc
    5 products
  • $AMRXAmneal Pharmaceuticals, Inc.
    4 products
  • Boehringer Ingelheim Corp
    4 products
  • Bristol-Myers Squibb Co
    4 products
  • Hyloris Pharmaceuticals SA
    4 products
  • Lupin Ltd
    4 products
  • Mylan Pharmaceuticals Inc
    4 products

Recent catalysts

view all →
Apr 30, 2026
phase 2 completion
7mo ago
Dutch Heart Foundation — ghrelin (Phase II Trial Completion)
ghrelin
→
Apr 30, 2026
phase 2 completion
7mo ago
Curtin University — influenza vaccine (Phase II Trial Completion)
influenza vaccine
→
Apr 30, 2026
phase 2 completion
7mo ago
National Institutes of Health — metformin hydrochloride ER (Phase II Trial Completion)
metformin hydrochloride ER
→
Apr 30, 2026
phase 2 completion
7mo ago
Sohag University — ephedrine (Phase II Trial Completion)
ephedrine
→
Apr 30, 2026
phase 2 completion
7mo ago
Neurodawn Pharmaceutical Co Ltd — Loberamisal (Phase II Trial Completion)
Loberamisal
→
Apr 30, 2026
phase 2 completion
7mo ago
Medical University of Gdansk — apixaban (Phase II Trial Completion)
apixaban ODT
→
Apr 30, 2026
phase 2 completion
7mo ago
Cancer Institute and Hospital Chinese Academy of Medical Sciences — lenvatinib (Phase II Trial Completion)
lenvatinib
→
Apr 30, 2026
phase 2 completion
7mo ago
Medanta - The Medicity — centhaquine citrate (Phase II Trial Completion)
centhaquine citrate
→
Apr 30, 2026
phase 2 completion
7mo ago
German Sport University Cologne — polyphenol-rich cocoa extract (Phase II Trial Completion)
polyphenol-rich cocoa extract
→
Apr 30, 2026
phase 1 2 completion
7mo ago
Implicit Bioscience Ltd — Atibuclimab (Phase I/II Trial Completion)
Atibuclimab
→

Recent news

view all →
  • Novartis projects slowed growth, pins hopes on billions in pipeline potential↗
    biospace · 6h ago
  • nChroma halves workforce, BioXcel lets execs go↗
    biospace · 7h ago
  • STAT+: In cancer drug development, the spotlight shifts onto Erasca’s KRAS-targeted treatment↗
    stat · 11h ago
  • Opinion: STAT+: I’m a cardiologist. I’m a little puzzled about the blockbuster new study on deprescribing statins↗
    stat · 13h ago
  • Novartis CEO argues shareholders ‘happy overall’ with strategy, calls for COINS Act adjustment↗
    fiercebiotech · 18h ago
  • STAT+: Influential preventive services panel to meet for first time in more than a year↗
    stat · 1d ago
  • CTAD 2026: BMS’ Cobenfy eases Alzheimer’s psychosis as expected but safety events raise questions↗
    biospace · 1d ago
  • Merck scraps centerpiece of $2.7B ArQule buy after late-stage safety concerns↗
    biospace · 1d ago
Data sources
openFDA · ClinicalTrials.gov · pharmadog Linker
last refreshed 3h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?